Data analysis on effects of therapeutic drug monitoring, dosing, and age on observed meprobamate concentrations in urine samples
Prior to the development of benzodiazepines (BZDs) in the 1950’s, a class of drugs known as tranquilizers were used in psychiatry to treat patients experiencing anxiety and fear as well as more challenging states of psychosis such as schizophrenia. The first minor tranquilizer and anxiolytic compou...
Main Author: | Iarussi, Paul J. |
---|---|
Other Authors: | Botch-Jones, Sabra R. |
Language: | en_US |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/43400 |
Similar Items
-
An evaluation of the efficacy and safety of meprobamate in combination analgesics and the likely economic impact of its withdrawal
by: Peter, Amanda, Clare
Published: (2018) -
Investigation of zolpidem in real urine samples at therapeutic doses level
by: Y A Khomov, et al.
Published: (2010-12-01) -
Avoidance-escape behavior in albino rats, as a function of anxiety reduction by behavioral techniques and meprobamate: Experimental study in the psychopathology of anxiety
by: Venkatramaiah, S R
Published: (2008) -
Therapeutic Drug Monitoring of Apixaban Using Chromogenic Kits
by: Vogel, Brooke
Published: (2020) -
Urine colorimetry for therapeutic drug monitoring of pyrazinamide during tuberculosis treatment
by: Isaac Zentner, et al.
Published: (2018-03-01)